Researchers found that dementia diagnoses based on Medicare Advantage (MA) encounter data can be reasonably accurate, but there are important considerations. A study from the Rush Alzheimer’s Disease Center examined how well these diagnoses matched rigorous cognitive assessments in a group of older adults. Among 508 participants, aged around 83 years on average, 12% were confirmed to have dementia through thorough cognitive testing. The study revealed that the MA encounter data had a positive predictive value of 63%, meaning it correctly identified a little over half of those with dementia, while the negative predictive value was quite high at 96%, indicating it was good at ruling out dementia in those without it.

This research is significant for anyone concerned about dementia and aging. As more people enroll in Medicare Advantage plans, understanding how well these plans identify dementia is crucial. The findings suggest that while MA encounter data can be a useful tool for researchers studying dementia prevalence, there may be a risk of misidentifying individuals with less severe impairments. This could impact the care and resources allocated to those who truly need them.

However, it’s important to note that this study is one of the first to validate dementia diagnoses in MA encounter data, based on a small sample size. While the results are promising, they are not definitive. The accuracy of these diagnoses needs further exploration, especially in larger populations and across different demographics. Overall, if you’re navigating Medicare options, it’s wise to be aware of how these diagnoses might affect your healthcare and support systems.